Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Luc Rochette, Charles Guénancia, Aurélie Gudjoncik, et al.
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 6, pp. 326-348
Open Access | Times Cited: 229

Showing 1-25 of 229 citing articles:

Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis
Luc Rochette, Geoffrey Dogon, Eve Rigal, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 449-449
Open Access | Times Cited: 377
Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs)
Loubna Mazini, Luc Rochette, Mohamed Amine, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2523-2523
Open Access | Times Cited: 349
Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
Liqun Zhao, Baolin Zhang
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 343
MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2
Lisha Zhao, Yan Qi, Lina Xu, et al.
Redox Biology (2017) Vol. 15, pp. 284-296
Open Access | Times Cited: 290
Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
Nadine Wenningmann, Merle Knapp, Anusha Ande, et al.
Molecular Pharmacology (2019) Vol. 96, Iss. 2, pp. 219-232
Open Access | Times Cited: 286
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
Simona Gallo, Annapia Vitacolonna, Alessandro Bonzano, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2164-2164
Open Access | Times Cited: 217
Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress
Lisha Zhao, Xufeng Tao, Yan Qi, et al.
Redox Biology (2018) Vol. 16, pp. 189-198
Open Access | Times Cited: 189
Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease
Matthias Totzeck, Martin Schüler, Martin Stuschke, et al.
International Journal of Cardiology (2019) Vol. 280, pp. 163-175
Closed Access | Times Cited: 186
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
Charles Guénancia, A. Lefèbvre, Daniela Cardinale, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 26, pp. 3157-3165
Open Access | Times Cited: 185
Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth
Mingchuan Li, Valentina Sala, Maria Chiara De Santis, et al.
Circulation (2018) Vol. 138, Iss. 7, pp. 696-711
Open Access | Times Cited: 179
New signal transduction paradigms in anthracycline-induced cardiotoxicity
Alessandra Ghigo, Mingchuan Li, Emilio Hirsch
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2016) Vol. 1863, Iss. 7, pp. 1916-1925
Closed Access | Times Cited: 177
Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway
Jian Yin, Jiabin Guo, Qiang Zhang, et al.
Toxicology in Vitro (2018) Vol. 51, pp. 1-10
Closed Access | Times Cited: 169
Chemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy
Bingjun Sun, Cong Luo, Weiping Cui, et al.
Journal of Controlled Release (2017) Vol. 264, pp. 145-159
Closed Access | Times Cited: 140
Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity
Giuseppina Milano, Vanessa Biemmi, Edoardo Lazzarini, et al.
Cardiovascular Research (2019)
Closed Access | Times Cited: 135
Trastuzumab cardiotoxicity: from clinical trials to experimental studies
Balázs Tamás Németh, Zoltán V. Varga, Wen Jin Wu, et al.
British Journal of Pharmacology (2016) Vol. 174, Iss. 21, pp. 3727-3748
Open Access | Times Cited: 122
Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ
Huan He, Yong Luo, Qiao Yang, et al.
Food & Function (2018) Vol. 9, Iss. 8, pp. 4404-4418
Closed Access | Times Cited: 105
Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies
Nanthip Prathumsap, Krekwit Shinlapawittayatorn, Siriporn C. Chattipakorn, et al.
European Journal of Pharmacology (2019) Vol. 866, pp. 172818-172818
Closed Access | Times Cited: 99
GDF15 and Cardiac Cells: Current Concepts and New Insights
Luc Rochette, Geoffrey Dogon, Marianne Zeller, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8889-8889
Open Access | Times Cited: 98
Apigenin attenuates doxorubicin induced cardiotoxicity via reducing oxidative stress and apoptosis in male rats
Masoud Zare, Kamran Rakhshan, Nahid Aboutaleb, et al.
Life Sciences (2019) Vol. 232, pp. 116623-116623
Closed Access | Times Cited: 92
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
Alessandra Murabito, Emilio Hirsch, Alessandra Ghigo
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 82
Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy
Luc Rochette, Alexandre Méloux, Marianne Zeller, et al.
Molecules (2020) Vol. 25, Iss. 10, pp. 2417-2417
Open Access | Times Cited: 73
Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway
Qianqian Jiang, Xu Chen, Xue Tian, et al.
Phytomedicine (2022) Vol. 106, pp. 154439-154439
Closed Access | Times Cited: 70
Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
Junqi Huang, Rundong Wu, Linyi Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 58
The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment
Mengmeng Lin, Weiping Xiong, Shiyuan Wang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 42
Apigenin-coated gold nanoparticles as a cardioprotective strategy against doxorubicin-induced cardiotoxicity in male rats via reducing apoptosis
Zeynab Sharifiaghdam, Seyed Mohammad Amini, Fereshteh Dalouchi, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14024-e14024
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top